MERCK & CO. INC. (6MK.DE) Stock Price, Quote, News and Overview
FRA:6MK - Deutsche Boerse Ag - US58933Y1055 - Common Stock - Currency: EUR
6MK.DE Quote, Performance and Key Statistics
MERCK & CO. INC.
FRA:6MK (2/5/2025, 10:32:42 AM)
87
+1.3 (+1.52%)
The current stock price of 6MK.DE is 87 EUR. In the past month the price decreased by -12.46%. In the past year, price decreased by -26.88%.
6MK.DE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY.DE | ELI LILLY & CO | 81.81 | 764.20B | ||
| 1LLY.MI | ELI LILLY & CO | 79.43 | 741.99B | ||
| ZEG.DE | ASTRAZENECA PLC | 18.22 | 413.69B | ||
| NOV.DE | NOVO NORDISK A/S-B | 28.95 | 365.07B | ||
| JNJ.DE | JOHNSON & JOHNSON | 15.25 | 355.12B | ||
| 1JNJ.MI | JOHNSON & JOHNSON | 15.23 | 354.69B | ||
| 1SAN.MI | SANOFI | 14.78 | 260.95B | ||
| SAN.PA | SANOFI | 14.6 | 257.64B | ||
| SNW.DE | SANOFI | 14.58 | 257.34B | ||
| 1MRKX.MI | MERCK & CO. INC. | 16.39 | 238.80B | ||
| 1PFE.MI | PFIZER INC | 10.24 | 145.02B | ||
| PFE.DE | PFIZER INC | 9.99 | 141.50B |
Related stock screener links
About 6MK.DE
Company Profile
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 72,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Human health vaccine products consist of preventive pediatric, adolescent and adult vaccines. The Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. The company is also engaged in developed a novel class of small molecules that target cancer cells lacking expression of a key DNA repair protein called O6-methylguanine methyl transferase.
Company Info
MERCK & CO. INC.
126 East Lincoln Avenue
Rahway NEW JERSEY US
Employees: 72000
Company Website: https://www.merck.com/
Investor Relations: https://www.merck.com/investor-relations
Phone: 19087404000
6MK.DE FAQ
What is the stock price of 6MK.DE?
The current stock price of 6MK.DE is 87 EUR.
What is the symbol for MERCK & CO. INC. stock?
The exchange symbol of MERCK & CO. INC. is 6MK and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is 6MK.DE stock listed?
6MK.DE stock is listed on the Deutsche Boerse Ag exchange.
Is 6MK.DE a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for 6MK.DE, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of 6MK.DE.
Does 6MK.DE stock pay dividends?
6MK.DE has a dividend yield of 3.27%. The yearly dividend amount is currently 2.94.
When does 6MK.DE stock report earnings?
6MK.DE will report earnings on 2025-02-04, before the market open.
What is the Price/Earnings (PE) ratio of 6MK.DE?
The PE ratio for 6MK.DE is 15.1. This is based on the reported non-GAAP earnings per share of 5.76 and the current share price of 87 EUR.
6MK.DE Technical Analysis
6MK.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to 6MK.DE. 6MK.DE has an excellent profitability rating, but there are some minor concerns on its financial health.
6MK.DE Financial Highlights
Over the last trailing twelve months 6MK.DE reported a non-GAAP Earnings per Share(EPS) of 5.76. The EPS decreased by 92.56% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 19.23% | ||
| ROA | 10.34% | ||
| ROE | 27.3% | ||
| Debt/Equity | 0.79 |
6MK.DE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 79% to 6MK.DE. The Buy consensus is the average rating of analysts ratings from 32 analysts.
For the next year, analysts expect an EPS growth of 406.8% and a revenue growth 6.67% for 6MK.DE